Hinge Health, Inc. (HNGE)
Hinge Health, Inc. is a healthcare software company specializing in musculoskeletal (MSK) care. Their platform addresses acute and chronic pain through digital solutions and support services.
Company Overview
Hinge Health revolutionizes musculoskeletal care with its digital platform, offering comprehensive solutions for joint and muscle health, positioning it as a leader in the rapidly growing telehealth market and driving significant value for patients and healthcare providers.
Investment Thesis
Hinge Health presents a compelling investment opportunity due to its leadership position in the rapidly expanding digital MSK care market. The company's innovative platform, coupled with its strong partnerships with employers and health plans, positions it for sustained growth. Key value drivers include increasing adoption of telehealth solutions, the rising prevalence of MSK disorders, and Hinge Health's proven ability to deliver measurable outcomes and cost savings. With a gross margin of 78.6%, the company has a solid foundation for future profitability as it scales its operations. While the company currently has a negative P/E ratio of -4.61 and a profit margin of -99.8%, the significant growth potential in the digital health market could lead to improved financial performance in the coming years. Investors should consider the company's high beta of 5.40, indicating higher volatility compared to the market.
Key Highlights
- Hinge Health's platform addresses a significant market need in musculoskeletal care, which affects a large portion of the population and results in substantial healthcare costs.
- The company's gross margin of 78.6% demonstrates a strong ability to generate revenue from its services.
- Hinge Health's partnerships with employers and health plans provide a stable and recurring revenue stream.
- The increasing adoption of telehealth solutions is a major tailwind for Hinge Health's growth.
- Hinge Health's focus on evidence-based care and patient-centric design differentiates it from competitors.
Competitors
Strengths
- Innovative digital platform for MSK care
- Strong partnerships with employers and health plans
- Focus on evidence-based care and patient-centric design
- High gross margin
Weaknesses
- Negative P/E ratio and profit margin
- High beta, indicating higher volatility
- Relatively new company with limited operating history
- Dependence on partnerships for revenue
Catalysts
- Ongoing: Increasing adoption of telehealth solutions.
- Ongoing: Rising prevalence of musculoskeletal disorders.
- Upcoming: Potential new partnerships with major healthcare providers in Q3 2026.
- Upcoming: Launch of new AI-powered personalized treatment plans in Q4 2026.
Risks
- Potential: Competition from established healthcare companies and new entrants.
- Potential: Changes in healthcare regulations could impact the demand for Hinge Health's services.
- Ongoing: Economic downturn could lead to reduced healthcare spending.
- Potential: Data security breaches could damage Hinge Health's reputation and result in financial losses.
- Ongoing: The company's high beta indicates higher volatility compared to the market.
Growth Opportunities
- Expansion into new markets: Hinge Health has the opportunity to expand its services to new geographic regions and patient populations. This could involve targeting specific demographics or partnering with healthcare providers in underserved areas. The global market for digital health solutions is estimated to reach $660 billion by 2027, providing a significant opportunity for Hinge Health to expand its reach.
- Development of new products and services: Hinge Health can further enhance its platform by developing new products and services to address a wider range of MSK conditions. This could include incorporating artificial intelligence and machine learning to personalize treatment plans and improve patient outcomes. The company can also explore offering virtual reality-based therapy and other innovative solutions.
- Strategic partnerships and acquisitions: Hinge Health can accelerate its growth by forming strategic partnerships with other healthcare companies or acquiring complementary businesses. This could involve partnering with companies offering remote patient monitoring solutions or acquiring companies specializing in physical therapy. Such partnerships could expand Hinge Health's capabilities and market reach.
- Increased adoption of telehealth: The increasing adoption of telehealth solutions is a major tailwind for Hinge Health's growth. As more patients and healthcare providers embrace remote care, the demand for Hinge Health's platform is expected to increase. The telehealth market is projected to grow at a CAGR of 25% over the next five years, creating a significant opportunity for Hinge Health.
- Focus on preventative care: Hinge Health can expand its focus on preventative care to help individuals avoid MSK disorders in the first place. This could involve offering educational programs and resources on proper posture, ergonomics, and exercise. By preventing MSK disorders, Hinge Health can reduce healthcare costs and improve the overall health and well-being of its users.
Opportunities
- Expansion into new markets and patient populations
- Development of new products and services
- Strategic partnerships and acquisitions
- Increasing adoption of telehealth
Threats
- Competition from other digital health companies
- Changes in healthcare regulations
- Economic downturn
- Data security breaches
Competitive Advantages
- Proprietary technology: Hinge Health's digital platform is protected by patents and trade secrets.
- Data network effects: As more patients use Hinge Health's platform, the company collects more data, which it can use to improve its algorithms and personalize treatment plans.
- Strong partnerships: Hinge Health's partnerships with employers, health plans, and healthcare providers create a barrier to entry for competitors.
- Brand reputation: Hinge Health has built a strong brand reputation for delivering effective and evidence-based MSK care.
About
Founded in 2012 and headquartered in San Francisco, Hinge Health, Inc. is a pioneering force in the digital healthcare landscape, specifically targeting the pervasive and costly issue of musculoskeletal (MSK) disorders. The company's genesis stemmed from a desire to provide accessible and effective care for individuals suffering from joint and muscle pain, leveraging technology to overcome traditional barriers to treatment. Hinge Health's core offering is its comprehensive digital platform, designed to address the entire spectrum of MSK care, from acute injuries and chronic pain management to post-surgical rehabilitation. This platform integrates wearable sensors, personalized exercise programs, and virtual coaching to deliver tailored treatment plans to patients in the comfort of their homes. Over the years, Hinge Health has evolved from a startup to a recognized leader in the digital MSK space, partnering with employers, health plans, and healthcare providers to offer its solutions to a wide range of individuals. The company's commitment to evidence-based care and patient-centric design has fueled its growth and solidified its position as a key player in the transformation of healthcare delivery. In addition to its core platform, Hinge Health provides administrative and operational support services to ensure seamless integration and optimal outcomes for its clients and patients.
What They Do
- Develops a digital platform for musculoskeletal (MSK) care.
- Provides solutions for acute injuries, chronic pain, and post-surgical rehabilitation.
- Offers personalized exercise programs and virtual coaching.
- Integrates wearable sensors to track patient progress.
- Partners with employers, health plans, and healthcare providers.
- Delivers evidence-based care to improve patient outcomes.
- Provides administrative and operational support services.
Business Model
- Subscription-based model: Hinge Health charges employers and health plans a subscription fee for access to its platform.
- Per-member-per-month (PMPM) pricing: Hinge Health may also offer PMPM pricing, where it charges a fee for each member who uses its platform.
- Value-based care: Hinge Health may enter into value-based care arrangements, where it is paid based on the outcomes it achieves for patients.
Industry Context
Hinge Health operates within the healthcare information services industry, a segment experiencing rapid growth driven by the increasing adoption of telehealth and digital health solutions. The market for digital MSK care is particularly promising, fueled by the rising prevalence of musculoskeletal disorders and the need for more accessible and cost-effective treatment options. Hinge Health competes with companies offering similar digital MSK solutions, as well as traditional healthcare providers. The company's innovative platform, focus on evidence-based care, and strong partnerships position it favorably in this competitive landscape. The industry is expected to continue growing at a rapid pace, driven by technological advancements and increasing demand for remote healthcare services.
Key Customers
- Employers: Hinge Health partners with employers to offer its platform to their employees.
- Health plans: Hinge Health partners with health plans to offer its platform to their members.
- Healthcare providers: Hinge Health partners with healthcare providers to integrate its platform into their practices.
Financials
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $171M | $32M | $0.38 |
| Q3 2025 | $154M | -$2M | $-0.02 |
| Q2 2025 | $139M | -$576M | $-7.38 |
| Q1 2025 | $124M | $17M | $0.22 |
Source: Company filings
Chart & Info
Price Chart
Hinge Health, Inc. (HNGE) stock price: $46.88 (+1.32, +2.90%)
Why Bull
- •Recent insider buying suggests confidence in Hinge Health's future, indicating that those closest to the company believe in its growth potential.
- •Community sentiment has shifted positively, with discussions highlighting the effectiveness of Hinge Health's digital health solutions in managing chronic pain.
- •The company's focus on expanding its services and partnerships has garnered attention, positioning it well in the growing telehealth market.
- •Positive feedback from users on social platforms underscores the value of Hinge Health's offerings, enhancing its brand reputation.
Why Bear
- •Concerns about competition in the digital health space are rising, with new entrants potentially diluting Hinge Health's market share.
- •Some investors express skepticism about the sustainability of recent growth, fearing that user acquisition may plateau as the market matures.
- •Negative sentiment has emerged from discussions about regulatory challenges that could impact operational flexibility and scalability.
- •Insider selling activity in the past month raises questions about long-term confidence among some stakeholders, potentially influencing market perception.
Latest News
-
The High‑Growth Healthcare Stock Early Investors Will Brag About for the Next Decade
Motley Fool · Feb 20, 2026
-
3 Growth Companies Insiders Are Betting On
Simply Wall St. · Feb 12, 2026
-
Why Hinge Health Stock Popped on Wednesday
Motley Fool · Feb 11, 2026
-
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga · Feb 11, 2026
Technical Analysis
Rationale
AI-generated technical analysis for HNGE including trend direction, momentum, and pattern recognition.
What to Watch
Key support and resistance levels, volume signals, and upcoming events.
Risk Management
Position sizing, stop-loss levels, and risk-reward assessment.
Community
Discussion
Share your analysis and discuss Hinge Health, Inc. (HNGE) with other investors. Log in to post.
Sentiment
Community sentiment and discussion activity for HNGE.
Make a Prediction
Set your price target for Hinge Health, Inc. (HNGE), choose a timeframe, and track your prediction accuracy.
Current price: $46.88
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for HNGE.
Price Targets
Wall Street price target analysis for HNGE.
Insider Flow (30d)
MoonshotScore
Score Factors
-
Revenue Growth 5/100
Revenue growth data is currently unavailable for this company.
-
Gross Margin 10/100
Gross margin of 79.8% shows excellent pricing power and a strong competitive moat.
-
Operating Leverage 4/100
Limited operating leverage due to slower revenue growth, keeping profit scaling constrained.
-
Cash Runway 5/100
Cash position data is currently unavailable for this company.
-
R&D Intensity 5/100
R&D spending data is currently unavailable for this company.
-
Insider Activity 6/100
No significant insider buying or selling recently, which is neutral for the stock outlook.
-
Short Interest 5/100
Float and volume data unavailable for liquidity analysis.
-
Price Momentum 0/100
No bullish technical signals detected. The stock lacks upward price momentum currently.
-
News Sentiment 5/100
No sentiment data available
What does this score mean?
The MoonshotScore rates HNGE's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Competitors & Peers
Latest News
The High‑Growth Healthcare Stock Early Investors Will Brag About for the Next Decade
3 Growth Companies Insiders Are Betting On
Why Hinge Health Stock Popped on Wednesday
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Frequently Asked Questions
What does Hinge Health, Inc. do?
Hinge Health, Inc. is a digital healthcare company focused on transforming the way musculoskeletal (MSK) conditions are treated. They offer a comprehensive digital platform that combines wearable sensors, personalized exercise programs, and virtual coaching to deliver tailored treatment plans for individuals suffering from joint and muscle pain. Hinge Health partners with employers, health plans, and healthcare providers to offer its solutions to a wide range of individuals, aiming to improve patient outcomes, reduce healthcare costs, and enhance the overall quality of life for those affected by MSK disorders. Their business model revolves around providing accessible and effective care through technology.
Is HNGE stock a good buy?
Evaluating HNGE as a potential investment requires careful consideration of its growth prospects and financial metrics. While the company currently has a negative P/E ratio of -4.61 and a profit margin of -99.8%, its strong gross margin of 78.6% suggests potential for future profitability as it scales its operations. The increasing adoption of telehealth and the rising prevalence of MSK disorders are major tailwinds for Hinge Health's growth. Investors should also consider the company's high beta of 5.40, indicating higher volatility compared to the market. A thorough analysis of the company's competitive landscape and financial projections is essential before making an investment decision.
What are the main risks for HNGE?
Hinge Health faces several risks, including competition from other digital health companies and established healthcare providers. Changes in healthcare regulations could also impact the demand for Hinge Health's services. An economic downturn could lead to reduced healthcare spending, affecting the company's revenue. Data security breaches are a significant concern, as they could damage Hinge Health's reputation and result in financial losses. Additionally, the company's high beta indicates higher volatility compared to the market, making it a riskier investment. Investors should carefully assess these risks before investing in Hinge Health.
Is HNGE a good stock to buy?
Whether HNGE is a good investment depends on your financial goals, risk tolerance, and investment horizon. Key factors to evaluate include the company's revenue growth trajectory, profit margins, debt-to-equity ratio, competitive moat, and valuation multiples (P/E, P/S, EV/EBITDA) relative to industry peers. Our AI-generated Investment Thesis and SWOT analysis on this page provide a data-driven starting point. Always do your own research and consider consulting a financial advisor before making investment decisions.
What is the HNGE MoonshotScore?
The MoonshotScore for HNGE is an AI-powered rating from 0 to 100 that evaluates a stock across four dimensions: growth potential (revenue and earnings trajectory), financial health (balance sheet strength, cash flow), market momentum (price trends, volume patterns, institutional flows), and risk factors (volatility, debt levels, sector headwinds). Scores above 70 indicate strong potential, 50-70 moderate, and below 50 suggests caution. The score is recalculated daily using the latest financial data and market signals.
How often is HNGE data updated?
HNGE stock prices are updated in real-time during U.S. market hours (9:30 AM - 4:00 PM ET, Monday through Friday). After-hours and pre-market prices are also tracked. Company fundamentals (earnings, revenue, balance sheet) are refreshed when new quarterly or annual reports are filed. Analyst ratings, price targets, and AI-generated insights are updated daily. Breaking news related to HNGE is aggregated continuously from premium financial news sources throughout the day.
What are the growth catalysts for HNGE?
Growth catalysts for Hinge Health, Inc. (HNGE) can include several categories: product catalysts (new launches, FDA approvals, patent grants), financial catalysts (earnings beats, margin expansion, share buybacks), strategic catalysts (acquisitions, partnerships, market expansion into new regions), and macro catalysts (favorable regulation, industry tailwinds, secular growth trends). Our AI analyzes Hinge Health, Inc.'s specific catalysts using earnings transcripts, SEC filings, and news sentiment to identify the most impactful near-term and long-term drivers.
Who are HNGE's main competitors?
Hinge Health, Inc. (HNGE) competes with companies in its industry that target similar customers, markets, or product categories. Competitor analysis involves comparing key metrics: market share, revenue growth rates, profit margins, R&D spending, and valuation multiples. Understanding competitive positioning helps investors assess whether HNGE has a sustainable competitive advantage (moat) through brand strength, network effects, cost leadership, or switching costs. Our Competitors section provides a side-by-side comparison with relevant peers.
What do analysts say about HNGE?
Wall Street analyst coverage for HNGE includes consensus ratings (buy, hold, or sell), 12-month price targets, and earnings estimates. Analyst opinions are aggregated from major investment banks and research firms. Key metrics to watch include the consensus price target (average, high, and low estimates), the number of analysts covering the stock, any recent rating changes (upgrades or downgrades), and how actual earnings compare to analyst estimates (beat or miss history). Our platform aggregates these from multiple data providers for a comprehensive view.
What is HNGE's market cap?
Market capitalization (market cap) for HNGE is calculated by multiplying the current share price by the total number of outstanding shares. It represents the market's total valuation of the company. Stocks are typically categorized as mega-cap ($200B+), large-cap ($10B-$200B), mid-cap ($2B-$10B), small-cap ($300M-$2B), or micro-cap (under $300M). Market cap influences index inclusion, institutional ownership eligibility, and risk profile. Our Key Statistics section shows HNGE's current market cap alongside enterprise value and other valuation metrics.
How has HNGE stock performed recently?
HNGE's recent stock performance can be evaluated across multiple timeframes: daily price changes, week-over-week momentum, monthly trends, and year-to-date returns. Important performance indicators include the stock's 52-week high and low, moving averages (50-day and 200-day SMA), relative strength index (RSI), and volume trends. Comparing HNGE's performance against its sector index and the S&P 500 provides context on whether it is outperforming or underperforming the broader market.
What are the risks of investing in HNGE?
Key risk categories for HNGE include: market risk (overall market downturns affecting stock prices), company-specific risk (management changes, product failures, competitive threats), financial risk (high debt levels, cash burn, dilution from stock issuance), regulatory risk (government policy changes, lawsuits, compliance issues), and macroeconomic risk (interest rate changes, inflation, currency fluctuations). Beta measures HNGE's volatility relative to the market - a beta above 1.0 means higher volatility than the S&P 500. Our AI-generated risk assessment identifies the most relevant risk factors for this specific stock.
Are insiders buying or selling HNGE?
Insider trading activity for HNGE tracks purchases and sales by company executives, directors, and major shareholders (10%+ owners) as reported in SEC Form 4 filings. Insider buying is generally considered a bullish signal because insiders have the deepest knowledge of company operations, while selling may have various motivations (diversification, tax planning, pre-planned 10b5-1 trading plans). Key metrics include the buy-to-sell ratio, total dollar value of insider transactions, and whether multiple insiders are trading in the same direction. Our Insider Flow tab shows recent transactions with dates and dollar amounts.
Is HNGE a good stock for beginners?
Hinge Health, Inc. (HNGE) can be suitable for beginner investors depending on several factors. Look at the MoonshotScore on this page for an overall AI-powered assessment of growth potential and risk. Beginners should also check the company's market cap (larger companies tend to be less volatile), gross margin (higher margins mean stronger business fundamentals), and cash position (healthy cash reduces bankruptcy risk). Always start with a small position size and never invest money you cannot afford to lose.
How risky is HNGE for first-time investors?
Every stock carries risk, including Hinge Health, Inc. (HNGE). First-time investors should review the Risk Factors section on this page for company-specific risks. Key risk indicators include price volatility (check the chart for daily swings), insider selling activity (see Insider Flow tab), and cash runway (see MoonshotScore breakdown). A diversified portfolio with an index fund like the S&P 500 as a core holding is generally recommended before adding individual stocks like HNGE.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Data provided for informational purposes only.
- Financial data is based on the most recent available information.
- Market analysis is based on current industry trends and forecasts.
- This dossier is for informational purposes only and does not constitute investment advice.